Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tissue concentrations of cefazolin and linezolid in sternal spongiosa during elective CABG
2011-005526-22Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2012
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cefazolin and linezolid, sponsored by Medical University of Vienna. Primary endpoints: Perioperative time–concentration profiles of cefazolin and linezolid in plasma and Perioperative time–concentration profiles of cefazolin and linezolid in sternal spongiosa. Started Mar 2012; status: completed.
02
Drugs
cefazolinlinezolid
Beyond the preview
Go deeper on 2011-005526-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005526-22.